HomeEXPRS2 • STO
add
ExpreS2ion Biotech Holding AB
Previous close
kr 15.30
Day range
kr 14.42 - kr 15.36
Year range
kr 14.00 - kr 34.20
Market cap
53.31M SEK
Avg Volume
12.77K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 3.53M | 62.21% |
Operating expense | 12.87M | -34.81% |
Net income | -8.18M | 46.44% |
Net profit margin | -231.39 | 66.98% |
Earnings per share | — | — |
EBITDA | -9.84M | 49.04% |
Effective tax rate | 18.23% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 47.56M | -41.68% |
Total assets | 65.11M | -37.94% |
Total liabilities | 29.42M | -26.65% |
Total equity | 35.69M | — |
Shares outstanding | 2.66M | — |
Price to book | 1.14 | — |
Return on assets | -40.12% | — |
Return on capital | -70.85% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -8.18M | 46.44% |
Cash from operations | 684.00K | 112.45% |
Cash from investing | — | — |
Cash from financing | 11.11M | 17.26% |
Net change in cash | 10.67M | 107.75% |
Free cash flow | 1.55M | 165.11% |
About
Founded
2015
Website
Employees
20
